Contact this trialFirst, we need to learn more about you.
Anti-fibrotic agent
Pirfenidone for Chronic Kidney Disease
Recruiting0 awardsPhase 2
San Diego, California
This trial will use MRI imaging scans and urinary markers to test the efficacy of pirfenidone as a treatment for kidney disease.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.